Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


LightCycler® 1536 Instrument

Product Description
Rapid, high-throughput, plate-based real-time PCR amplification and detection instrument.

The LightCycler® 1536 Instrument is a rapid, plate-based, thermal block cycler with integrated real-time, online detection capabilities. The architecture of this novel high-throughput platform is built upon the proven LightCycler® 480 Instrument with its high-performance optical unit and block cycler technologies.
The LightCycler® 1536 optical unit facilitates mono- and dual-color assays using the dyes FAM, VIC/Yellow555, BrightGreen and others by supporting formats including Universal Probe Library (UPL) probes, hydrolysis probes, and intercalating dyes (e.g., BrightGreen). The unique thermal block cycler design in combination with the LightCycler® 1536 Multiwell Plate enables very high well-to-well homogeneity and inter-assay reproducibility.
The LightCycler® 1536 Software supports the generation of real-time PCR results (e.g., Cp’s, endpoint fluorescence values), providing novel threshold functions for data refinement, and powerful tools for data sorting and reviewing. Since this system is designed for automated high-throughput laboratory workflows, the instrument’s software allows easy data management for network and LIMS environments. In combination with the RealTime ready reagents, representing the next generation of real-time PCR chemistry, the system offers a new surveillance concept that checks for pipetting errors.
Product LightCycler® 1536 Instrument
Company Roche - Products Listing
Price Request a quote
More Information View company product page
Catalog Number 05334276001
Quantity 1 instrument
Company Logo

Roche - Products Listing
Roche Diagnostics Corporation Roche Applied Science P.O. Box 50414 9115 Hague Road Indianapolis, IN 46250-0414 US

Tel: +1-800-428-5433
Fax: +1-800-428-2883



Scientific News
Grant Supports Project To Develop Simple Test To Screen For Cervical Cancer
UCLA Engineering announces funding from Bill and Melinda Gates Foundation.
Loss Of Y Chromosome Increases Risk Of Alzheimer’s
Men with blood cells that do not carry the Y chromosome are at greater risk of being diagnosed with Alzheimer’s disease. This is in addition to an increased risk of death from other causes, including many cancers. These new findings by researchers at Uppsala University could lead to a simple test to identify those at risk of developing Alzheimer’s disease.
Making Virus Sensors Cheap and Simple
Researchers at The University of Texas at Austin demonstrated the ability to detect single viruses in a solution containing murine cytomegalovirus (MCMV).
Heart Defect Prediction Technology Could Lead to Earlier, More Informed Treatment
Experimental method uses genetics-guided biomechanics, patient-specific stem cells.
Biosensor Detects Molecules Linked to Cancer, Alzheimer's and Parkinson's
Novel biosensor has been proven capable of detecting molecules associated with neurodegenerative diseases and some types of cancer.
Big Data Can Save Lives
The sharing of genetic information from millions of cancer patients around the world could be key to revolutionising cancer prevention and care, according to a leading cancer expert from Queen's University Belfast.
Fast, Simple Test for Colitis
A minimally invasive screening for ulcerative colitis using emerging infrared technology could be a rapid and cost-effective method for detecting disease that eliminates the need for biopsies and intrusive testing of the human body.
Scans Reveal Babies of Mothers with Gestational Diabetes Have More Body Fat
Researchers at Imperial College London have found that the babies born to mothers with gestational diabetes have more body fat at two months of age compared to babies born to healthy mothers.
New Device Could Improve Cancer Detection
UBC researchers develop a microfluidic device to capture circulating tumor cells.
Plasma Biomarkers for Breast Cancer Diagnosis
Plasma lipidomics profiling identified lipid biomarkers in distinguishing early-stage breast cancer from benign lesions.

Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!